Maze Therapeutics Inc (MAZE)

Jul 15, 2025

Why Maze Therapeutics Inc. stock attracts strong analyst attentionFree Real-Time Trading Opportunities - Newser

Jul 15, 2025

Jul 15, 2025

How Maze Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser

Jul 15, 2025

Jul 15, 2025

What makes Maze Therapeutics Inc. stock price move sharplyProfitable Yet Secure Picks - Newser

Jul 15, 2025

Jul 11, 2025

Maze Therapeutics (NASDAQ:MAZE) Research Coverage Started at Wedbush - Defense World

Jul 11, 2025

Jul 11, 2025

Q2 Earnings Estimate for Maze Therapeutics Issued By Wedbush - Defense World

Jul 11, 2025

Jul 11, 2025

Brokerages Set Maze Therapeutics, Inc. (NASDAQ:MAZE) Target Price at $23.50 - Defense World

Jul 11, 2025

Jul 10, 2025

Maze Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Jul 10, 2025

Jul 10, 2025

Maze Therapeutics Showcases Precision Medicine Pipeline at Major Kidney and Biotech Investor Conferences - Stock Titan

Jul 10, 2025

Jul 10, 2025

Maze Therapeutics Soars 11.68% on Wedbush's Outperform Rating - AInvest

Jul 10, 2025

Jul 08, 2025

Maze Therapeutics' Development Strategy Using Genetic Validation Seen as Promising, Wedbush Says - MarketScreener

Jul 08, 2025

May 29, 2025

Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference - GlobeNewswire

May 29, 2025

May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025

May 21, 2025

Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Ionis Pharmaceuticals (IONS) and Maze Therapeutics, Inc. (MAZE) - The Globe and Mail

May 21, 2025

May 19, 2025

Positive Outlook for Maze Therapeutics: Buy Rating Reiterated Amid Promising Drug Developments and Strong Financial Position - TipRanks

May 19, 2025

May 18, 2025

Comparing DBV Technologies (NASDAQ:DBVT) and Maze Therapeutics (NASDAQ:MAZE) - Defense World

May 18, 2025

May 16, 2025

Contrasting Repligen (NASDAQ:RGEN) & Maze Therapeutics (NASDAQ:MAZE) - Defense World

May 16, 2025

May 14, 2025

Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones - GlobeNewswire

May 14, 2025

May 14, 2025

Maze Therapeutics Q1 Earnings: Dual Clinical Programs Progress as Cash Position Hits $294M - Stock Titan

May 14, 2025

May 13, 2025

Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference - The Manila Times

May 13, 2025

May 13, 2025

Maze Therapeutics CEO to Present Company Overview at 3rd Annual H.C. Wainwright BioConnect Investor Conference - Nasdaq

May 13, 2025

May 01, 2025

Maze Therapeutics Inc (MAZE)’s Day in Review: Closing at 9.25, Up by 5.23 - DWinneX

May 01, 2025

Apr 30, 2025

Maze Therapeutics (NASDAQ:MAZE) versus Vaxcyte (NASDAQ:PCVX) Financial Survey - Defense World

Apr 30, 2025

Apr 25, 2025

Maze Therapeutics (NASDAQ:MAZE) Shares Down 19.4% – Here’s What Happened - Defense World

Apr 25, 2025

Apr 11, 2025

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 11, 2025

Apr 08, 2025

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Apr 08, 2025

Apr 04, 2025

Guggenheim Reiterates Buy Rating for Maze Therapeutics (NASDAQ:MAZE) - Defense World

Apr 04, 2025

Apr 04, 2025

Leerink Partnrs Has Bearish Forecast for MAZE Q1 Earnings - Defense World

Apr 04, 2025

Mar 31, 2025

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Maze Therapeutics reports Q4 EPS ($18.32) vs ($11.46) last year - TipRanks

Mar 31, 2025

Mar 26, 2025

Maze Therapeutics: Interesting Science But IPO-Related And Other Risks Exist (NASDAQ:MAZE) - Seeking Alpha

Mar 26, 2025

Mar 20, 2025

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Mar 20, 2025

Mar 20, 2025

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 20, 2025

Mar 17, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 17, 2025

Mar 05, 2025

Maze Therapeutics, Inc.’s (NASDAQ:MAZE) Quiet Period To End on March 12th - Defense World

Mar 05, 2025

Mar 01, 2025

Leerink Partners Begins Coverage on Maze Therapeutics (NASDAQ:MAZE) - MarketBeat

Mar 01, 2025

Mar 01, 2025

Maze Therapeutics (NASDAQ:MAZE) Stock Price Up 5.6%Still a Buy? - MarketBeat

Mar 01, 2025

Feb 28, 2025

Maze Therapeutics (NASDAQ:MAZE) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat

Feb 28, 2025

Feb 28, 2025

Guggenheim Begins Coverage on Maze Therapeutics (NASDAQ:MAZE) - MarketBeat

Feb 28, 2025

Feb 28, 2025

Maze Therapeutics (NASDAQ:MAZE) Stock Rating Upgraded by Leerink Partnrs - MarketBeat

Feb 28, 2025

Feb 28, 2025

FY2024 Earnings Forecast for MAZE Issued By Leerink Partnrs - Defense World

Feb 28, 2025

Feb 28, 2025

Maze Therapeutics (NASDAQ:MAZE) Upgraded at TD Cowen - Defense World

Feb 28, 2025

Feb 27, 2025

FY2024 Earnings Estimate for MAZE Issued By Leerink Partnrs - MarketBeat

Feb 27, 2025

Feb 27, 2025

Maze Therapeutics (NASDAQ:MAZE) Coverage Initiated at JPMorgan Chase & Co. - Defense World

Feb 27, 2025

Feb 27, 2025

Maze Therapeutics (NASDAQ:MAZE) Coverage Initiated at Guggenheim - Defense World

Feb 27, 2025

Feb 27, 2025

Maze Therapeutics (NASDAQ:MAZE) Raised to “Strong-Buy” at Leerink Partnrs - Defense World

Feb 27, 2025

Feb 26, 2025

Maze Therapeutics initiated with a Buy at TD Cowen - TipRanks

Feb 26, 2025